Results 301 to 310 of about 237,114 (381)

Cocoa waste valorization: a review and sustainability analysis of green technologies

open access: yesBiofuels, Bioproducts and Biorefining, EarlyView.
Abstract Cocoa residues – notably cocoa pod husks and cocoa bean shells – can be valorized for biocompound recovery, bioenergy production, and waste reduction. This review analyzed 1115 publications related to this field to identify key research trends. Interest is increasing in compounds such as theobromine, bioactive substances, adsorption processes,
Susan Haydeé Soriano Morales   +4 more
wiley   +1 more source

Studies on Mode of Action of Organo Phosphorus Fungicide, Kitazin Part I

open access: bronze, 1969
Kazuo Kakiki   +3 more
openalex   +2 more sources

Minimizing the enzyme dosage for ethanol production from cellulose‐rich bagasse residues after furfural production

open access: yesBiofuels, Bioproducts and Biorefining, EarlyView.
Abstract Through consolidated bioprocessing, cellulosic ethanol production from sugarcane bagasse residues emanating from furfural production (furfural residues, FRs) may offer substantial cost reductions compared with conventional pretreatment–hydrolysis–fermentation of lignocelluloses. Furfural residues have a high enzymatic digestibility and require
Godrick E. Bunga   +4 more
wiley   +1 more source

Efficacy and safety of empagliflozin for treating neutropenia and neutrophil dysfunction in paediatric patients with glycogen storage disease type Ib: A systematic review and meta‐analysis

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Glycogen storage disease type Ib (GSD‐Ib) is a rare genetic disorder causing neutropenia and neutrophil dysfunction in children. G‐CSF has been the primary treatment, but emerging data support the potential of empagliflozin, an SGLT2 inhibitor, as a promising investigational option.
Elizabeth Iwasyk   +5 more
wiley   +1 more source

<i>CYP51</i> alterations in <i>Alternaria solani</i> and their effects on DMI sensitivity and fitness. [PDF]

open access: yesAppl Environ Microbiol
Schroeder AC   +5 more
europepmc   +1 more source

Challenges in optimizing tacrolimus therapy in patients treated with rifampin: A case series

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Tacrolimus is a cornerstone immunosuppressant in transplantation medicine with a narrow therapeutic window. Drug–drug interactions with strong CYP3A4 and P‐glycoprotein modulators, such as rifampin and azole antifungals, significantly alter tacrolimus exposure and complicate therapy. Two transplant cases illustrates the impact of rifampin on tacrolimus
Jeroen P. A. Houwen   +6 more
wiley   +1 more source

Innovative transdermal drug delivery systems: Benefits, challenges, and emerging application

open access: yesBMEMat, EarlyView.
The graphical abstract illustrates the diverse nanostructures employed in transdermal drug delivery systems, highlighting their unique mechanisms to penetrate the intricate layers of skin. It provides a detailed representation of the skin's complex anatomy, emphasizing the challenges posed by its barrier properties.
Syed Waqas Ali Shah   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy